The Protein Brewery, a Dutch company specialising in fungi-derived food ingredients, has raised €30m ($35.40m) in its Series B funding round.
The company intends to use the funds to support expansion of its production capacity and commercial roll-out of its proprietary ingredient Fermotein.
The company stated the funding will also be directed towards strengthening sales and application expertise, with market launches planned in the US and Europe.
Its Mijkenbroek facility will undergo expansion, while activities in Singapore are also being scaled up.
The round was joined by new investors such as Invest-NL and the Brabant Development Agency (BOM), alongside existing investors Novo Holdings, Unovis Asset Management and Madeli.
Invest-NL investment manager Daan Meijer said: ”With its unique fermentation-based solution, The Protein Brewery stands out in the alternative protein space and strengthens the Netherlands’ leadership in food innovation.
“As a Dutch company driving the proteintransition, The Protein Brewery is setting a new standard in sustainability, a vision we are proud to support.”
Founded in 2020, The Protein Brewery develops food ingredients through fermentation technologies aimed at contributing to sustainable nutrition.
The Protein Brewery CEO Thijs Bosch said: “This funding is a springboard for global expansion. With Fermotein, we are not just offering another protein – we are redefining how food is made: nutritious, sustainable, and scalable at a lower cost. The Protein Brewery is ready to lead the protein and fibre transition.
“We are now entering a defining moment: all building blocks of operation are in place, and we are ready to accelerate.”
Fermotein, its lead product, is a protein- and fibre-rich ingredient intended for use in bakery products, snacks, dairy substitutes, protein beverages, nutritional bars and meal replacements.
The company produces Fermotein with a proprietary fungal strain and a patented method.
Launches with US partners are expected in the coming months, while entry into the EU and UK markets will follow pending regulatory clearance.
Novo Holdings partner Thomas Grotkjær said: ”The Protein Brewery has built the infrastructure, laid the groundwork, and is now positioned to bring biotech-driven food innovation to the global stage.
“This funding fuels its ability to drive real impact in the food industry.”
